Factor I of the anthrax toxin was isolated and showed one major component in the ultracentrifuge and on paper electrophoresis; it contained less than 5.5% of extraneous antigens detectable by serological precipitation in gels. The final preparation contained all the usual amino acids (N = 10*1%) and some carbohydrate (6 yo, calculated as glucose) and phosphorus (0.7 yo). The most striking aspects of its analysis were a high ash (10-13y0) and a light absorption a t 260 mp. The high ash was not due to one element but to a highly variable metal content (mainly Ca, Mg, Ni, Cu) indicating a powerful and indiscriminate chelating action of factor I. This chelating action might have been due to the chemical entity which absorbed light a t 260 mp and which was not RNA or DNA.
INTRODUCTION
The specific lethal and oedema-forming toxin of Bacillus anthracis was first recognized in vivo and then produced in vitro; it consisted of a t least two components -factors I and II-which acted synergistically (Smith, . This paper describes the purification, biological action and chemical properties of factor I of anthrax toxin.
Crude factor I from toxin produced in vitro. A modification of the method of Thorne et al. (1960) was used. A culture (1 1.) containing crude antigen of Bacillus anthracis (Thorne & Belton, 1957; Strange & Thorne 1958 ) was passed through a sintered-glass bacterial filter (6 cm. diameter; 5/3 porosity), which was washed with 0.05~-phosphate buffer (pH7; 4 x 20 ml.) at 0-2". On extraction of the filter for 1 hr. with ice-cold saturated Na,CO, solution (4 ml.) followed by neutralization of the extract with HC1 a solution of crude factor I was obtained. One batch of culture contained 40-100 1. and 40-100 filters were washed and extracted within 2 hr. of filtration of the original culture.
Crude factor II from the toxin produced in vitro. This was precipitated from the filtrate of the culture described above, by ammonium sulphate as described by Strange & Thorne (1958) and dialysed for 6 hr. at 0-2" against buffered saline (0.01 ~-2-amino-2-hydroxymethylpropane-l:3-diol (tris buffer) in saline; pH 7.4).
Purijied preparation of factor 11 of the anthrax toxin produced in vitro. This was the preparation of Strange & Thorne (1958) described by Sargeant et al. (1960) .
Mr J. L. Clipson for these determinations. mined by the methods described by Smith et al. (1955b) .
RESULTS

Pur$cation and properties of factor I of the anthrax toxin PuriJication of factor I on diethylaminoethyl cellulose (DEAE-C).
A solution of crude factor I (200 ml. = 50 1. original culture; factor I null point 1/500; protein content about 0.06 yo) a t pH 7-44 was diluted with 0 . 0 0 5 ,~ phosphate buffer (1800 ml. ; pH 7.4) and applied to a column (4.5 cm. diameter, 10 cm. length) of DEAE-C (25 g . ) which had been packed at 4 lb./sq.in. pressure and equilibrated with 0 . 1 ,~ phosphate buffer (pH 7.4). The flow rate was adjusted to 20 ml./min. by application of a slight positive pressure. The effluent (2000 ml.) had negligible activity and the column was eluted successively with quantities (450 ml.) of 0.1, 0.12, 0.15, 0-17 and 0.2,~ phosphate buffers (pH 7.4). In preliminary experiments each application of buffer was collected as a single fraction (450 ml.); the bulk (60-90 yo) of the factor I activity was eluted by the 0.15 and 0 . 1 7 ,~ buffers.
In subsequent experiments the eluates from the applications of the 0.15 and 0 . 1 7 ,~ buffers were each collected in 6 x 75 ml. fractions. Each fraction was purified and concentrated in the following manner. Each fraction (75 ml.) was diluted with distilled water (225 ml.) and applied to a column (2 cm. diameter, 1 cm. length) of DEAE-C (0.2 g.) equilibrated with 0 . 1 ,~ phosphate buffer (pH 7.4). No pressure was applied and the flow rate was 5-10 ml./min. The effluent (300 ml.) contained only a small amount of factor I activity but over 75% of the original material reacting as protein in the method of Lowry et al. (1951) . The column was washed J. L. STANLEY AND H. SMITH once with 0 . 1 ,~ phosphate buffer (6 ml.; pH 7.4) and the active material eluted in 0-2p phosphate buffer (pH 7.2) containing ~/ 5 NaCl (4 ml.). Before combining any active fractions for further processing the 12 concentrated fractions from the eluates with 0.15 and 0.17,~ buffers were examined separately on serological diffusion plates for the presence of impurities. Preliminary work showed that factor I was associated with a line formed on serological precipitation plates against ' spore ' anthrax antiserum (H. 533), whereas it formed no line against 'antigen' antiserum (H25) (see Sargeant et al. 1960) . On serological diffusion plates the 12 concentrated fractions formed against anthrax antisera faint extraneous lines in a pattern which varied slightly from batch to batch but was usually as indicated in Table 1 . Appropriate fractions (usually 3-8, but in each experiment the inclusion of fractions 2,9 and 10 or exclusion of fractions 3," and 8, depending on the particular pattern of lines formed by the fractions on serological diffusion plates) from this and a second similarly fractionated batch (200 ml.) of crude factor I, were combined, dialysed overnight at 0-2' against 0.02,~ phosphate buffer (pH 7.4) and applied to a column (0.5 cm. diameter, 3 cm. long) of DEAE-C (80 mg.) equilibrated with 0.02,~ phosphate buffer (pH 7.4). The effluent (about 50 ml.) contained negligible activity. The column was eluted with 0 . 2~ phosphate buffer (pH 7.2) containing M / 5 NaCl. The first 0.4 ml. of eluate, which contained negligible activity, was discarded. The next 0.8 ml. constituted the final preparation of factor I which was kept at -20' until required.
Yield and recovery of activity. In five similar experiments, 0.8 ml. of final product having an average factor I null point of 1/64,000, containing about 0. For most experiments, the final product was used as prepared in solution and stored at -20". For chemical analysis the solution was dialysed for 7 days a t 0-2' against frequent changes of distilled water until free from salt and then freeze-dried.
After this prolonged dialysis 50 % of the original activity was lost; after freezedrying, the material was not completely soluble, 
Criteria of purity
Ultracentrifugation. The final preparation (0.7 yo) showed one major component when examined in a synthetic boundary cell at pH 7.4 in 0 . 2 ,~ phosphate buffer (see Fig. 1 ).
Paper electrophoresis. The final preparation was concentrated by dialysis against carbowax. The material (0-3 mg.) showed no evidence of heterogeneity when examined in 0 -2~ barbitone buffer (pH 8.6) and 0 -2 p acetate buffer (pH 5 ) ; it was almost stationary but it did move from the origin, towards the anode a t pH 8-6 and towards the cathode at pH 5.
Serological precipitation in gel di8usion plates. Experiments described in an addendum to this paper indicated that two extraneous serologically-reacting materials were present in the final product, but that the degree of contamination was not more than 0.5 yo of one material and 5 yo of the other.
Biological properties Oedema production. In the assay for factor I activity about 0.02pg. produced an oedematous reaction when mixed with the standard quantity of factor 11, but 6pg. produced no reaction when injected alone. The material was stable a t -20" a t pH 7 for 1-2 months, but at 0-2' 50 yo of factor I activity disappeared after 7 days a t pH 7, and 75% was lost after 7 days a t pH 5 and 9. The material (in 0 . 2~ phosphate buffer, pH 7.4) lost 50 yo of its activity in 2 hr. at 37", 75 yo of its activity when shaken with glass beads for 1 hr. at 0" and all of its activity on standing for 24 hr. at 0' with cysteine (0.2 yo), sodium metabisulphite (0.1 yo) and potassium periodate (0.05 yo).
Lethality to mice (see below)
Serological precipitation in gels. The behaviour of the final preparation of factor I was described by Sargeant et al. (1960) . The line associated with factor I activity was just formed by 0.5pg. of the final preparation in serological diffusion plates against 'spore' anthrax antiserum (H 533); no line was formed against 'antigen' anthrax antiserum (H 25) unless the material was examined at high concentrations (see above).
Immunizing activity. In the assay for immunizing activity in guinea pigs 12Opg. of the final preparation showed no significant activity. Similarly, 40pg. or lOOpg. of the final preparation did not immunize rabbits (10 rabbits were used in each batch and the material was mixed with horse serum before injection). Table 2 summarizes the chemical analyses of the final product, Fig. 2 shows its infrared spectrum and Fig. 3 (curve A) its ultraviolet absorption spectrum in neutral solution. The material was not solely protein, although it contained much amino acid material; it had no significant amount of lipid and some carbohydrate residues. The most striking aspect of its chemical analysis was a high metal content as shown by its high ash, and an apparent nucleic acid content (about 6-8 % from its absorption at 260 mp) and its P content. These aspects were investigated in more detail.
Chemical properties
The metal content. The high ash of the final material seemed to be a specific property and not due to the fractionation process. Thus, ovalbumin, rabbit y-globulin, human serum albumin and two samples of factor I1 of anthrax toxin had 1.3, 2.7, 0.9, 0.6 and 1.2% sulphate dashes, respectively, after being subjected to the same fractionation process as that described above for factor I. The high ash was not due to the presence of SiO, (or B,OJ since heating with HF did not decrease it.
The nature of the metal content was investigated by spectroscopic analysis. Mg, Ca, Ni and Cu were present in appreciable amounts in the four batches of material examined; only traces of other metals were present. The estimated contents (which were subject to an error of & 100 yo due to the small amount of material examined and the necessity of estimating all metals on one sample) of the four batches fell in the ranges (%): Mg, 0-001-0.1; Ca, 0-003-0-8; Ni, 0.3-0-75; Cu, 0.1-1.3; but the relative proportions were not consistent from batch to batch. In attempts to remove the metal content or a t least to obtain a consistent pattern, four batches of active material were prepared as described above but with the use of deionized water throughout the process and DEAE-C columns which had been pretreated with ethylenediaminetetraacetic acid (EDTA) to remove metals as follows: 100 g. DEAE-C were treated with 4 1. 0.1 yo EDTA overnight, decanted, re-treated with a further 4 1.0.1 yo EDTA and washed with 3 x 4 1. 0 . 1~ phosphate buffer (pH 7.4). The sulphated ash of the final material (11.3 and 12.6y0 on two of the batches) was not decreased by these precautions, although the nature of the metal content changed to some extent; the Ni and Cu content appeared to be decreased (range Ni 0.12-0.19 % ; Cu 0.1-0.5 yo) and the Mg and Ca content increased (range Mg 0.17-1.1 %; Ca 0.3-1.0 %). It appeared that the preparation of factor I had a chelating action on most metals and that no single metal was characteristic of the preparation.
The absence of R N A and DNA. The following observations were carried out in collaboration with our colleague Mr H. E. Wade, (1) Adequate control experiments showed that the absorption of U.V. radiation was not due to the high Ni and Cu content. (2) Although in neutral solution the U.V. absorption spectrum of the final preparation of factor I (Fig. 3, curve A) resembled the spectrum of a mixture of 10% yeast RNA in ovalbumin (Fig. 3, curve B) , the shifts in their spectra (Fig. 3 , curves C and D, respectively) in O~~N -K O H were different. The absorption of the experimental sample at 260 mp was less than that at neutral pH, whereas the absorption of the artificial mixture of nucleic acid +protein was greater than at neutral pH. Furthermore, in alkali the experimental sample showed a characteristic plateau of absorption at 270-295 mp which was not shown by the control mixture. was added and the precipitate removed by centrifugation and reserved (see below) ; the extract was clarified by adding ovalbumin solution (0.1 ml., 0.2 yo) and recentrifugation. The spectra of the extracts, which should contain all the ribonucleotides from RNA if present, were examined under acid (as prepared) and alkaline (after adding 20 N-KOH to make the solution 0.1 N-KOH and removing the KClO, by centrifugation) conditions. The spectra of the extracts from the control mixture containing RNA were as expected; practically all the original material absorbing a t 260 mp was soluble in acid after alkaline hydrolysis and the extinction (-log T ) of the extract at 240 mp was less than that a t 260 mp under both acid and alkaline conditions. In contrast, the spectra of the extract from the experimental sample [ Fig. 4 , curves A (acid conditions) and B (alkaline conditions)] showed that much of the material in the original sample which absorbed a t 260mp had not been liberated by alkaline hydrolysis (compare Fig. 3 , curve C with Fig. 4 , curve B) and that the extracted material was not the usual mixture of ribonucleotides, i.e. there was a large increase of absorption at 240 mp (relative to that at 260 m p ) when the conditions changed from acid to alkaline. The absence of ribonucleotides in this extracted material was confirmed by paper ionophoresis (Wade, 1961) . The hydrolysate was neutralized with HClO, and concentrated in a desiccator before applying to the paper. A comparison with a similar extract from the control mixture of RNA+protein indicated that the original sample of factor I contained less than 0.6% RNA. (4) The absence of DNA was indicated by the following hydrolytic studies. The material precipitated by HClO, after alkaline hydrolysis of the final preparation of factor I, including the deposit centrifuged after clarification with ovalbumin, was suspended in water (3 ml.) and heated with HClO, solution (0.15 ml., 72%, w/v) for 15 min. at 90". A deposit was centrifuged from the cooled product and the spectrum of the supernatant fluid examined (Fig. 4 , curve C); it showed no evidence for the presence of hydrolytic products of DNA. On the other hand, when the deposit from this acid hydrolysis was dissolved in water (3ml.) at pH 7 (addition of 5 N-NaOH), its spectrum showed that it still retained material absorbing at 260 and 240 mp (Fig. 4, curve D) . ( 5 ) In a micro-adaptation of the diphenylamine method for deoxysugars (Volkin & Cohn, 1954) no colour was formed by the final preparation of factor I (90 pg.), whereas 2.5 pg. of DNA (thymus) produced a colour.
Recognition of a third factor of the anthrax toxin The low toxicity for mice of oedema-producing mixtures of puri$ed factors I and I I . The results in the top half of Table 3 show that the final preparation of factor I and a purified preparation of factor I1 produced no oedema in rabbits and did not kill mice when large amounts were injected alone, but that smaller quantities injected together produced large skin reactions in rabbits and killed some mice. However, the lethality of these mixtures for mice was much smaller than that warranted by their capacity for oedema production when compared with results of similar experiments with crude preparations (see bottom half Table 3 ). Thus, crude unseparated anthrax toxin produced in vivo and in vitro killed more mice at concentrations which produced a relatively smaller amount of oedema in rabbits; and the same type of result was obtained by injecting mixtures of crude factors I and I1 which, like the purified factors, did not when injected alone produce oedema in rabbits and were almost non-toxic for mice. The finding that some factor which con-tributed to lethality for mice was present in either crude factor I or I1 and absent from the purified preparation, was indicated by the results shown in the last two lines of Table 3 . In contrast to mixtures of purified I and 11, mixtures of either crude I +purified I1 or purified I + crude I1 killed mice, although they produced a relatively small skin reaction in rabbits. ( ' protein ' ).
f-A skin reaction of size 17:75 means that the oedematous lesion had a fold thickness of 17 mm. and a diameter of 75 mm. Significant differences were 2 mm. in fold thickness or 10mm. in diameter ; these differences were produced by 24-fold differences in toxin concentrations.
Enhancement of the lethality for mice and oedema production in rabbits of mixtures of purijied factors I and I I by adding serum and other proteins. The possibility that the effect of the constituents of the crude preparations described above was a nonspecific action of extraneous protein (e.g. possibly by protecting the toxin against destruction in the mouse) was investigated. The results in Table 4 show that the specific lethality for mice of mixtures of the final preparation of factor I +purified factor I1 was significantly increased by adding various sera and proteins. However, the addition of this extraneous protein also increased the skin reactions; the increase was about 2-4-fold when compared by the more sensitive null point assay, and the anomaly described above regarding size and skin reaction and lethality for mice IP: 54.70.40.11
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remained. This effect of serum and other proteins only occurred with mixtures of the purified factors ; in similar experiments with crude preparations extraneous proteins had little or no effect on oedema production or on lethality for mice.
Fractionation of a third factor of the anthrax toxin.
A factor was sought which, when added to a mixture of purified factors I and 11, would form a preparation which killed mice at concentrations that produced in rabbits a relatively small skin reaction. Preliminary experiments showed that such a factor was present in fractions collected from the chromatography of crude factor I on DEAE-C when the column was eluted with 0 . 2 ,~ phosphate buffer after factor I had been removed with more dilute buffers (see previously). The factor was also present in those fractions discarded during the purification of factor I1 by the method of Strange & Thorne (1958). A preparation of this factor I11 was produced for the experiments described below by the following method. Table 4 
. Effect of serum and other proteins on oedema production and lethal eflect of mixtures of purified anthrax toxin factors I and 11
The lethal and oedema-producing effects were completely neutralized when horse anthrax antiserum (spore H533) was used instead of the other sera.
Material in 0.5 ml. Horse serum
22/25
Rabbit serum
18/30
Guinea-pig serum
8/10
Sodium polyglutamate (1 yo)
415
Saline
0115
Horse serum
4/25
3/10
Sodium polyglutamate (1 yo) * When injected alone these preparations did not kill mice (0.5 ml.) or evoke oedema (0.2 ml.)
$ The null point was the first dilution of two fold descending dilutions which did not form an in rabbits.
oedematous skin reaction.
? See Table 3 .
Filtrate ( 5 1.) from a culture containing crude anthrax toxin (see Methods) was applied to a column (4.5 cm. diam.; 4 cm. long) of DEAE-C ( 5 g.) which had been equilibrated with 0 . 1 ,~ phosphate buffer (pH 7.4). No pressure was applied and the flow rate was about 30 ml./min. Factor I11 was retained on the column and most of the factor I1 was not.
The column was eluted with: (1) 0 . 1 5 ,~ phosphate buffer (60 ml.; pH 7.4); (2) 0 . 2 ,~ phosphate buffer (60 ml.; pH 7.4); (3) 0 . 2 ,~ phosphate buffer containing 0.05~-NaC1 (60 ml.; pH 7.4); (4) 0 . 2~ phosphate containing 0.2M-NaCI (180 ml.; pH 7.2). Factor I11 was eluted by buffer (4); 15 ml. fractions of this were collected, assayed for protein and appropriate fractions corresponding with the elution peak were concentrated in the following manner. The bulked fractions from 5 batches of filtrate were dialysed against 0 . 1~ phosphate buffer (pH 7.4, 0-2", overnight) and applied to a column (2 cm. diam.; 1 cm. length) of DEAE-C (0.2 9.) which had been equilibrated with 0 . 1~ phosphate buffer (pH 7.4). No pressure was applied and the flow rate was 5-10 ml./min. Factor I11 was eluted with 0 . 2 ,~ phosphate buffer containing 0.2 ~-NaC1(8 ml.). This preparation of factor I11 contained 0.15 yo protein. In gel diffusion plates against 'spore' antiserum (H533) it (10,ug.) formed two lines which were also formed by crude anthrax toxin produced in vivo and by an impure preparation of factor I from this source (see Stanley et al. 1960) ; these lines were different from those formed by the final preparations of factor I (see above) and of purified factor I1 (see Sargeant et al. 1960) . Against 'antigen' (H25) antiserum the preparation of factor I11 formed a line which very easily dispersed and dissolved in antigen excess, indicating a low content of factor I11 antibody in this antiserum. Table 3 . $ These lethal and oedema producing effects were completely neutralized in adequate batches O / l O mice respectively and produced no oedema in the skin of rabbits. The results shown in Table 5 indicate that: (1) In common with factors I and 11, factor I11 was non-lethal for mice and produced no oedema in rabbits when injected alone in large amount. showed synergic action in toxicity tests in mice and produced a greater effect than expected from the addition of the effects of the pairs of factors described in (3). Table 6 shows the statistical analysis of the cogent results, for which we are indebted to our colleague Mr S. Peto. ( 5 ) The addition of factor I11 to a mixture of factors I and I1 decreased the size of the oedematous skin reactions produced in rabbits. (6) All these toxic effects were neutralized by anthrax antiserum.
Injection of a mixture of factors I, I1 and I11 (about 10 and 20 times the amounts which killed mice) killed guinea pigs (see Table 7 ). This toxicity was neutralized by anthrax antiserum. Observations were made during the terminal phase on two of the guinea pigs (250-300 g.) killed by the mixtures of factors I, I1 and 111. For comparison corresponding observations were made on a few normal animals; these were the same as those described by Smith et al. (1955a, b) . The two animals died with the clinical signs of shock; their bleeding volumes (Smith et al. 1955a, b ) were low (about 4 ml.) and their plasma inorganic phosphate and non-protein-N contents were high (PO,---, 10-5, 15.5; non-protein-N, 100, 85 mg./100 ml.). Evidence that oligaemia contributed to the shock syndrome in these guinea pigs (compare guinea pigs dying of anthrax and from injection of crude anthrax toxin produced in vivo; see Smith et al. 1955a , b) was provided by the fact that their haematocrit values were high (about 50 yo) and their plasma protein contents low (500 and 475 mg. N/lOO ml.).
One guinea pig had a gross subcutaneous oedema comparable with that seen when some but not all guinea pigs die from anthrax.
DISCUSSION
In any comparison between the final preparations of factor I of the anthrax toxin produced in vitro (as described here) and that produced in vivo , and subsequent unpublished observations), it must be remembered that whereas the former preparation was relatively pure, the latter was known to contain some constituents of guinea pig plasma (about 15 %) and to be serologically heterogeneous in gel diffusion against anthrax antisera. Bearing this in mind, the two preparations resembled each other in being unstable, having a high ash content, absorbing light a t 260 mp, being almost stationary when electrophoresed on paper a t pH 8.6, containing much protein but having a relatively low N content, and having a small carbohydrate and phosphorus content (the latter might conceivably be due to a strong binding of phosphate from the buffers used in the process). The two preparations were quite different in three respects, however: (1) The preparation from the in vivo source tended to aggregate and sediment more rapidly in the ultracentrifuge than that from the in vitro source. (2) The preparation from the in vivo source contained much lipid (probably serum lipid) whereas the other preparation did not. (3) The preparation from the in vivo source immunized animals, whereas the present preparation did not.
The most striking chemical property of factor I of the anthrax toxin was its high and complete metal content, the nature of which was not consistent from batch to batch. Factor I was not an acid, binding the metals by a purely ionic linkage, because it did not migrate rapidly when electrophoresed on paper a t pH 8.6. It appeared therefore that factor I had a strong and indiscriminate chelating action on the metals which were present in the original culture medium (this contained CaCl, , MgSB, and ' Casamino Acids ' with a high ash) and in materials (e.g. DEAE-C) used for purification. The chelating action might be due to the presence of the chemical group which absorbed light at 260 mp and which was not RNA or DNA; this might be the same group that produced in alkaline solution a characteristic ' blip ' in the U.V. absorption at about 293 mp. The nature of this group is at present unknown; the main difficulty in its investigation is the very small amount of material available for experiment. The metal-binding activity of factor I may be the reason for its biological action but this is not proven; a 0.1 yo (w/v) solution of EDTA did not replace factor I in the biological assays.
A comparison of the nature of the biological properties of a mixture of final preparation of factor I +purified factor I1 with those of crude materials led to the demonstration of a third factor of the anthrax toxin. This factor was partially purified from crude factor I1 produced in vitro, and shown to be different from factors I and I1 and present in the anthrax toxin produced in vivo by serological methods. Table 8 summarizes the biological relationship between the three factors. The reason for the decrease in skin reaction when factors I and I1 were mixed with factor I11 is not clear. Possibly factor I11 helps in the dispersion of the other factors and leads to a smaller local action. In contrast to the action of factor 111, the addition of serum to factors I and I1 increased their capacity for local oedema production as well as the mouse lethality, probably by a non-specific protective effect. Although it was shown that mixtures of factors I, I1 and I11 showed synergism in mouse toxicity tests, it was impossible to obtain the optimal proportions of the three factors because of the large amount of material and the number of mice needed for a comprehensive titration. For the same reason, although it was shown that guinea pigs were killed specifically by injecting a mixture of the three factors, the determination of their optimal proportions and the demonstration of synergism in guinea pigs was precluded. The guinea pigs killed by the mixtures of the three factors died with some of the symptoms of oligaemic secondary shock as did guinea pigs dying of infection (Smith et aZ. 1955 b) . The existence of a third factor of the anthrax toxin possessing the properties described above explains an apparent anomaly in previous results (see , Table 2 , line 3) when the injection of a mixture of crude in vitro antigen +crude factor I1 prepared in vivo killed mice, but did not produce a large skin reaction. The demonstration of three factors of the anthrax toxin leads to speculation as to whether at one time they were joined, a t least in a loose complex, and to whether mixtures of the factors would immunize animals better than any individual factor.
Our thanks are due to Mr F. C. Belton for producing the anthrax toxin in vitro and to Mr R. Blake for excellent technical assistance.
NOTE ON SEROLOGICAL PRECIPITATION IN GELS AS A CRITERION OF PURITY OF ANTIGENS
By H. SMITH, K. SARGEANT and J. L. STANLEY
In the purification of factors I and I1 of the toxin of BaciZZzLs anthracis Sargeant et al. 1960) serological precipitation in gels was used as a criterion of purity of antigens. This focused our attention on a problem which we think is evaded in similar studies on bacterial and other products and which warrants some discussion.
A purified product may be obtained which shows no evidence of heterogeneity when examined ultracentrifugally or electrophoretically in the conventional manner. At an arbitrarily chosen concentration, the product may form one major non-composite (cf . Sargeant et a,? . 1960) line in serological diffusion plates against a strong antiserum. However, this same antiserum may detect many antigenic impurities since it is prepared by hyperimmunizing animals with either the original mixture of antigens, or with the appropriate live organism. Hence, when higher (and occasionally lower) concentrations of the purified product are diffused against this antiserum further faint lines may appear, indicating the presence of antigens in addition to the one forming the major line; these additional antigens can usually be demonstrated in other fractions discarded during the separation of the final product. The difficulty is to know how one can be reasonably certain that the antigens which produce the additional lines are not present in the purified product in large amounts, The fact that, at the concentration examined, these additional lines are fainter than the major line does not necessarily mean that the antigens producing them do not predominate in the product under examination. The antigens in question might be present in large amounts but precipitated feebly in the test system, e.g. they might be poor antigens and hence the serum relatively deficient with their precipitating antibodies. When the serological behaviour of products on gel-diffusion plates is described there is usually no mention of the concentrations at which the material first formed one line and then more lines. Furthermore, if one line were formed, no assessment is made of the purity of the product on the basis of relative weights of the precipitating antigens.
We propose a practical working rule for studies of this kind which, although not foolproof, sets a standard of assessment of impurity on a weight basis comparable with the conventional methods of analytical electrophoresis and ultracentrifugation. Usually in the latter procedures a full examination of the product does not take place because of the large effort involved and especially because of the lack of sufficient material. As a compromise, the material is generally examined at one or two pH values a t concentrations near I%, w/v. Such examinations can indicate that the product is not grossly heterogeneous but they will not detect less than 5 % of impurity. The object of the following procedure with the gel-diffusion method is to make reasonably certain that extraneous antigens, which are usually more easily detected by this method than by other methods, do not exceed about 5 % of the final product.
The final product is examined in one of the conventional systems of gel diffusion. This should be accurately described and the antiserum used should be the one which will detect the largest number of antigenic impurities. Concentrations of 0.5-1 yo to 0.001 yo are examined for the production of extraneous lines (cf. Sargeant et al. 1960) and then the importance of these lines is assessed by titrations. It is assumed that the line-forming ability of any antigen does not vary in different preparations.
The determination by titration in gel-diffusion plates of the amount of extraneous antigens in a purified product would be a simple matter if pure preparations of these antigens were available for comparison; but usually this is not so, since the extraneous antigens are unknown and may be of no importance except as impurities in the final product. However, if we are aiming a t the standard of assessment of impurities described above, quite crude samples of extraneous antigens are suitable for comparative titrations. The aim is to obtain a discarded fraction from the purification process, which in a gel-diffusion system forms a line at a concentration about 20 times less than the lowest concentration of purified preparation which forms this same line against the same antiserum in the same system. If this can be achieved, it means the purified product contains less than about 5 % of the extraneous antigen. This contamination may be far less than about 5 % , if the sample of extraneous antigen used for comparative titrations contained little of the active material. If a t first this 20-fold difference in the titrations cannot be obtained, it might be more profitable to spend time purifying the extraneous antigen sufficiently to attain the desired difference in titrations, rather than to attempt to remove from the purified product what may be a relatively small contamination with extraneous antigen. When the final product, which passes this criterion of purity, is examined chemically, it would be advisable to check that any peculiar chemical attribute is not possessed by the (impure) samples of extraneous antigens.
As an example, the final preparation of factor I of the anthrax toxin produced in vitro-described above-was examined by the above procedure. In addition to the line associated with factor I activity, which did not appear to be composite, the final preparation (0.5 yo, w/v) formed one faint line against ' spore ' antiserum (H533). Against 'antigen' antiserum (H25) it (0.5 yo, w/v) formed two faint lines. The faint line formed with antiserum H 533 corresponded with one of the two lines formed with antiserum H25 and both lines were due to extraneous antigens, since they were formed by smaller amounts of relatively inactive fractions discarded during fractionation of factor I. A short purification of these inactive fractions on diethylaminoethyl cellulose columns produced samples of each extraneous antigen ; these were used in comparative titrations with the final preparation of factor I on gel diffusion plates against both types of anthrax antiserum. These titrations indicated that the final preparation of factor I was contaminated with not more than 0.5y0 of one extraneous serologically-reacting material and not more than 5 yo of the other.
